Click ESC to get back to this page


Early monitoring of B cells on Ocrelizumab may help to identify those at risk of adverse effects

Chandni Radia, Lead Pharmacist Neurosciences, Imperial College Healthcare NHS Trust

How COVID-19 influenced MS Service in Hull – Implementation of Official Guidelines and Recommendations

Dr Iulia Danciut, Associate Specialist, Hull University Teaching Hospitals NHS Trust

The Use of Vitamin D in Multiple Sclerosis, is there a Consensus?: Do we over or under test, over or under treat ?What should we advise our patients ?

Shannon Gaughan, MS Advanced Nurse Practitioner, United Lincolnshire Hospitals NHS Trust

Management of lymphopenia associated with dimethyl fumarate and fingolimod

Brina Bharkhada, MS Specialist Pharmacist, National Hospital for Neurology and Neurosurgery

The Ocrelizumab Pharmacy Service at the Leeds Teaching Hospitals NHS Trust (LTHT): Improving the Patient Experience

Jeremy Robson & Sumrah Shaffiq, Advanced Clinical Pharmacists, Leeds Teaching Hospitals NHS Trust

Taking over an MS service under pressure: 12 month review

Dr Yasser Falah, Consultant Neurologist, Nottingham University Hospitals NHS Trust

Multidisciplinary MS consultation

Dr Nele Glibert, General Neurologist, AZ Groeninge Hospital

Royal Free Neurorehabilitation Center MS coffee mornings: a novel approach to meeting the needs of people with progressive MS

Bhawani Devi Mainali, MS Nurse Specialist, Royal Free NHS Foundation Trust

Multiple Sclerosis management during the COVID-19 pandemic

Dr Ricardo Reis, Neurologist Resident, Centro Hospitalar de São João

Does mode of referral influence time to diagnosis?

Dr Catherine Donaldson, Neurology Specialty Doctor, Southern Health NHS Foundation Trust

Time is brain: Analysis of patient seen in Multiple Sclerosis clinic in Hull

Mariam Hussain, Speciality Doctor, Hull University Teaching Hospitals NHS Trust

Can MS Nurses Help Reduce Non-Elective Admission?

Gale Metcalfe, MS Specialist Nurse, Leeds Teaching Hospitals NHS Trust
& Audrey Owen, MS Nurse, Calderdale and Huddersfield NHS Foundation Trust

Re-opening & redesigning of the Ocrelizumab (Ocrevus ®) infusion service following the first wave of the COVID-19 Pandemic

Gosia Kuran, Lead MS Nurse Specialist, King’s College Hospital